Articles By Olga Petryna, MD
Pegloticase in Severe Refractory Gout
By Olga Petryna, MD
25 November 2020
Listen as Dr. Petryna reviews abstracts #0683 (Pharmacokinetics of Pegloticase and Methotrexate Polyglutamate(s) in Patients with Uncontrolled Gout Receiving Pegloticase and Co-treatment of Methotrexate) and #0677 (A Multicenter, Efficacy and Safety Study of Methotrexate to Increase Response Rates in Patients with Uncontrolled GOut Receiving Pegloticase (MIRROR): 12-Month Results of an Open-Label Study) from the 2020 ACR meeting.
Read Article
Diagnostic tools in autoinflammatory syndromes
By Olga Petryna, MD
10 November 2020
With broader awareness about the disease state, early diagnosis and treatment in autoinflammatory syndromes, and its life threatening complication Macrophage Activation Syndrome, remains a huge unmet need.
Read Article
Diagnostic Delay in Psoriatic Arthritis: What are the Consequences?
By Olga Petryna, MD
06 November 2020
Despite increased awareness and better diagnostic modalities at hand, early diagnosis of psoriatic arthritis (PsA) still remains a huge unmet need.
Read Article
Are we doing our best treating seronegative arthritides?
By Olga Petryna, MD
09 June 2020
Every time a big scientific meeting ends I ask myself a question: how is it going to affect the way I treat my patients? This year the question pertains to management of axial spondyloarthropathies and psoriatic arthritis.
Read Article
Pegradicase+ImmTOR SEL-212 Shows Promising Results In Active Gout
By Olga Petryna, MD
25 November 2019
Therapies targeting sUA accumulation or improving its excretion are widely used for treatment of symptoms and prevention of progression of gout for decades.
Read Article
PANLAR Ultrasound Study Group: Recommendations On Imaging Modalities In Gout
By Olga Petryna, MD
20 November 2019
Gout is a systemic inflammatory disease with high potential for joint damage due to erosive changes and MSU deposits resulting in disability and chronic pain. Prompt diagnosis and effective treatment are key to better long term outcomes and decreased disability.
Read Article
Several Studies Addressed Treatment of Axial Spondylitis
By Olga Petryna, MD
22 October 2018
Monday afternoon's session on the treatment of Axial Spondyloarthritis presented us with a great selection of studies addressing important issues in modern treatment paradigm of AxSpA.
Read Article
The Great Debate: Plaquenil - Choosing Safety over Efficacy?
By Olga Petryna, MD
21 October 2018
I am usually thrilled to offer Plaquenil as one of the safer therapy options to my patients with lupus and other autoimmune conditions.
Read Article
Gout Takeaways
By Olga Petryna, MD
16 June 2018
The annual EULAR meeting just came to an end today. Rooms are gradually emptying out. People look both content to have updated their knowledge and relieved that four very busy days have concluded. Time to summarize.
Read Article
High Biologic Blood Levels Increases the Risk of Infections in RA
By Olga Petryna, MD
15 June 2018
A big concern of most is the risk of infection with use of tumour necrosis factor inhibitor (TNFi) and biologic drugs. While studied in both trials and in post-marketing studies, it is unknown if infection risk is dose-dependent.
Read Article